The NSW Opioid Treatment Program (OTP) seeks to reduce the social, economic and health harms associated with opioid use. The OTP delivers pharmacotherapy and associated services to opioid dependent patients in NSW through the public sector (including Justice Health) and private sector (private clinics, general practitioners, psychiatrists and community pharmacies). There are currently 3 types of opioid pharmacotherapy available in NSW: methadone, buprenorphine and buprenorphine-naloxone.
In general, OTP prescribers are required to obtain authority from the NSW Ministry of Health prior to their prescribing under the program. Contact a Senior Pharmaceutical Officer at Pharmaceutical Services on (02) 9424 5921 during business hours to confirm the validity of an authority.
To supply methadone or buprenorphine (including buprenorphine-naloxone) under the NSW OTP a pharmacist requires registration with the Ministry of Health using the Application to Become a Registered Opioid Treatment Program (OTP) Dosing Point.
Note, the application form includes the protocol for supplying methadone or buprenorphine under the NSW OTP (TG201).
There are a number of requirements that must be met before an application will be considered:
Completed forms should be submitted to Pharmaceutical Services by email to MOH-PharmaceuticalServices@health.nsw.gov.au or fax to (02) 9424 5860.
Applications are generally processed within 5 business days. Note that methadone and/or buprenorphine cannot be ordered from a supplier until the registration process is completed.
Re-registration to supply methadone and/or buprenorphine under the NSW OTP is required in the following circumstances:
For changes to a registered OTP pharmacy, use the Application to Become a Registered Opioid Treatment Program (OTP) Dosing Point.
To minimise disruption to the supply of methadone and/or buprenorphine to the pharmacy, applications for re-registration should be submitted in advance but no earlier than 7 business days before changes (in name, ownership, etc.) take effect. Fax completed form to Pharmaceutical Services on (02) 9424 5860.
To improve the quality of NSW Opioid Treatment Program (OTP) dose administration services, a self-audit tool is now available for community pharmacies in NSW.
Community pharmacists provide an essential contribution to the NSW OTP with an important role in reducing opioid-related harms in our communities. From early 2019, the Pharmaceutical Regulatory Unit (PRU) will undertake regular audits of NSW dose administration points, including community pharmacies providing OTP services to strengthen the safety and quality standards of service delivery across NSW.
To assist pharmacies, a pharmacy self-audit tool has been developed collaboratively by the NSW Ministry of Health, Pharmacy Guild and Pharmaceutical Society of Australia. Use the tool to:
If you have any questions about the program, the self-audit tool or the Pharmacy Incentive Scheme, please contact the Pharmacy Guild of Australia (NSW branch) on (02) 9467 7100 or firstname.lastname@example.org
Contact NSW Drug & Alcohol Specialist Advisory Services (DASAS) on (02) 9361 8006 in Sydney metropolitan area or 1800 023 687 in NSW regional/rural areas for clinical advice on the diagnosis and clinical management of patients with alcohol or other drug related problems